Evidence map›Paper›PMID 39995874›Full record

ArticleiScience2025

Differentiation of high risk prostate cancer with a facile urinary exosome detection workflow.

Shuai Qiu, Yue Li, Zheng Zhang, Chunchang Li, Haoyu Wang, Ao Chen, Zhi Yan, Yang Liu, Zifei Li, Hua Huang and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in iScience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Shuai QiuState Key Laboratory of Experimental Hematology & The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Medical Technology & School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Yue LiState Key Laboratory of Experimental Hematology & The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Medical Technology & School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Zheng ZhangDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Chunchang LiDepartment of Urology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Haoyu WangDepartment of Urology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Ao ChenState Key Laboratory of Experimental Hematology & The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Medical Technology & School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Zhi YanState Key Laboratory of Experimental Hematology & The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Medical Technology & School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Yang LiuDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Zifei LiDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Hua HuangDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Yi LiuSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China.
Yiqi SeowGenome Institute of Singapore (GIS), Agency for Science, Technology and Research (A∗STAR), Singapore 138673, Republic of Singapore.
Ruibing ChenSchool of Pharmaceutical Science and Technology, Tianjin University, Tianjin 300072, China.
Jinhong GuoSchool of Sensing Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China.
Simeng WenDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Jing TianDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Hongtuan ZhangDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Ranlu LiuDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Gang HanState Key Laboratory of Experimental Hematology & The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Medical Technology & School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.
Baolong WangDepartment of Urology, Tianjin Medical University General Hospital, Tianjin 300052, China.
Yong WangDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
Yuanjie NiuDepartment of Urology, The Second Hospital of Tianjin Medical University, Tianjin Institute of Urology, Tianjin 300211, China.
HaiFang YinState Key Laboratory of Experimental Hematology & The Province and Ministry Co-sponsored Collaborative Innovation Center for Medical Epigenetics, School of Medical Technology & School of Basic Medical Sciences, Tianjin Medical University, Tianjin 300070, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Clear differentiation of high-grade and clinically insignificant prostate cancer (PCa) is critical for clinical decision-making. Here, we developed a proprietary urinary exosome isolation approach (EVLatch) and established a facile diagnostic workflow. We discovered that

Indexed as

Biological sciencesCellular neuroscienceNatural sciencesNeuroscienceTechniques in neuroscience

Identifiers

PMID39995874
PMCPMC11848465

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.